RH
Raghib Husain
About Raghib Husain
Data last updated:
Raghib Husain is a Director at Indbio Research Private Limited (since 2023) and Designated Partner at Toxpeer Preclinical Consultancy Services Llp (since 2019). The companies operate in Research & Development. The largest current company by reported revenue is Indbio Research Private Limited at ₹12,083 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Jun 2023 | 2021 | ₹12,083 (FY 2025) | Active | |
| Designated Partner | 24 Apr 2019 | 2019 | Active |
Board colleagues of Raghib Husain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Karthikeyan Sumana | 09063002 | Indbio Research Private Limited | Director |
| Mohammed Halal Bilal | 09063001 | Indbio Research Private Limited | Director |
| Hibah Husain | 08432234 | Toxpeer Preclinical Consultancy Services Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raghib Husain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raghib Husain
Raghib Husain currently holds 2 directorships: Indbio Research Private Limited (Director, since 09 Jun 2023, revenue ₹12,083 (FY 2025)); Toxpeer Preclinical Consultancy Services Llp (Designated Partner, since 24 Apr 2019).
Raghib Husain was first appointed on 24 Apr 2019 as Designated Partner at Toxpeer Preclinical Consultancy Services Llp. The most recent appointment on record is 09 Jun 2023 at Indbio Research Private Limited.
The current boards of Raghib Husain's companies include Karthikeyan Sumana (Indbio Research Private Limited), Mohammed Halal Bilal (Indbio Research Private Limited), Hibah Husain (Toxpeer Preclinical Consultancy Services Llp).